PDS BIOTECHNOLOGY CORP
2.1900
29-November-24 12:45:00
15 minutes delayed
Stocks
+0.0400
+1.86%
Today's range
2.1300 - 2.2250
ISIN
N/A
Source
NASDAQ
-
PDS Biotechnology Appoints Spencer Brown as Senior Vice President, General Counsel
03 Jun 2022 07:00:00 By Nasdaq GlobeNewswire
-
PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101
02 Jun 2022 07:00:02 By Nasdaq GlobeNewswire
-
PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe
31 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
26 May 2022 16:02:00 By Nasdaq GlobeNewswire
-
26 May 2022 16:01:00 By Nasdaq GlobeNewswire
-
25 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
18 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
PDS Biotech to Participate at Upcoming Investor Conferences
17 May 2022 07:00:04 By Nasdaq GlobeNewswire
-
PDS Biotech Provides Business Update and Reports First Quarter 2022 Financial Results
11 May 2022 06:00:02 By Nasdaq GlobeNewswire
-
PDS Biotechnology Announces Conference Call and Webcast for First Quarter 2022 Financial Results
28 Apr 2022 07:00:02 By Nasdaq GlobeNewswire
-
27 Apr 2022 09:01:00 By Nasdaq GlobeNewswire
-
PDS Biotech Chief Medical Officer, Lauren V. Wood, to Chair Session at the World Vaccine Congress
20 Apr 2022 07:00:00 By Nasdaq GlobeNewswire
-
19 Apr 2022 07:00:01 By Nasdaq GlobeNewswire
-
PDS Biotechnology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Apr 2022 07:00:00 By Nasdaq GlobeNewswire
-
PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2021 Financial Results
31 Mar 2022 06:00:02 By Nasdaq GlobeNewswire
-
22 Mar 2022 18:30:00 By Nasdaq GlobeNewswire
-
15 Mar 2022 06:45:00 By Nasdaq GlobeNewswire
-
09 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
PDS Biotechnology to Present at the 32nd Oppenheimer Annual Healthcare Conference
01 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
24 Feb 2022 09:10:00 By Nasdaq GlobeNewswire